Galectin Therapeutics
Price & Volume
Stats
See moreOpen | $3.68 |
Previous Close | $3.67 |
Day Range | $3.44-$3.68 |
52W Range | $2.03-$7.13 |
Market Cap | $370.1M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.45 |
News
See moreYahoo Finance • 16 days ago
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
Yahoo Finance • last month
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
Yahoo Finance • 2 months ago
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
Yahoo Finance • 2 months ago
Galectin Aligns With FDA Feedback To Advance Belapectin In MASH Cirrhosis And Portal Hypertension
About
CEO | Mr. Joel Lewis CPA |
CFO | Mr. Jack W. Callicutt CPA |
Address | 4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |